Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $28.76 Million |
|---|---|
| Enterprise Value | $30.50 Million |
| Earnings per Share | $-0.6 |
| Beta | 1.38 |
| Outstanding Shares | 22,667,842 |
| P/E Ratio | -3.07 |
|---|---|
| PEG | 34.36 |
| Price to Sales | 1.66 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.86 |
| Enterprise Value to EBIT | -3.38 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.59 |
| Debt to Equity | 0.91 |
No data
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 7.42%▼ 0.08% |
|---|---|
| Total Invested | $4.80M▼ 34.94% |
| Investors Holding | 18▼ 2.00% |
BioHarvest Sciences Inc. is a biotechnology company that operates through two segments: Products and CDMO Services. The company has developed a botanical synthesis platform technology to grow plant cells with higher concentrations of act...